Cargando…
Molecular Docking as a Potential Approach in Repurposing Drugs Against COVID-19: a Systematic Review and Novel Pharmacophore Models
PURPOSE OF REVIEW: This article provides a review of the recent literature related to the FDA-approved drugs that had been repurposed as potential drug candidates against COVID-19. Moreover, we performed a quality pharmacophore study for frequently studied targets, namely, the main protease, RNA-dep...
Autores principales: | Fadlalla, Mohamed, Ahmed, Mazin, Ali, Musab, Elshiekh, Abdulrhman A., Yousef, Bashir A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970976/ https://www.ncbi.nlm.nih.gov/pubmed/35381996 http://dx.doi.org/10.1007/s40495-022-00285-w |
Ejemplares similares
-
Histone H3 Mutations in Cancer
por: Wan, Yi Ching Esther, et al.
Publicado: (2018) -
Colchicine in COVID-19: an Old Drug, New Use
por: Schlesinger, Naomi, et al.
Publicado: (2020) -
Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2
por: Satarker, Sairaj, et al.
Publicado: (2020) -
Pipeline Pharmacological Therapies in Clinical Trial for COVID-19 Pandemic: a Recent Update
por: Kumari, Puja, et al.
Publicado: (2020) -
The Case Fatality Rate in COVID-19 Patients With Cardiovascular Disease: Global Health Challenge and Paradigm in the Current Pandemic
por: Dan, Siddhartha, et al.
Publicado: (2020)